Automated External Defibrillator (AED) - Market Insights, Competitive Landscape, and Market Forecast - 2030

Automated External Defibrillators Market by Product Type (Wearable and Non-Wearable), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of cardiovascular disorders and the rising product developmental activities worldwide

The automated external defibrillators market is estimated to grow at 8.62% CAGR during the forecast period from 2024 to 2030. The automated external defibrillator market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the automated external defibrillators market during the forecast period from 2024 to 2030.

Automated External Defibrillators Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to the updated data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally. According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world.

Automated external defibrillators are crucial in managing cardiovascular diseases and conditions like atrial fibrillation and CAD. For individuals experiencing sudden cardiac arrest, automated external defibrillators can deliver an electric shock to restore a normal heart rhythm, which is vital in emergencies. In cases of atrial fibrillation, where the heart's rhythm becomes irregular, these can be used to reset the heart's rhythm to its normal state. These devices can be life-saving in instances where CAD leads to cardiac arrest. Their use helps improve survival rates by providing timely intervention and increasing the chances of successful resuscitation during critical moments.

Increased product developmental activities by regulatory bodies worldwide is also slated to witness market growth for automated external defibrillators. For example, in January 2024, Element Science received a CE mark in Europe and approval in the U.K. for its patch-based cardioverter defibrillator, designed to offer a more wearable option for individuals at risk of sudden cardiac arrest who may not qualify for or prefer not to have a long-term implant.

As per data provided by the World Health Organization 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. As the global population ages, with a significant increase in individuals over 60 years old, who are more susceptible to cardiac events, automated external defibrillators play a vital role in emergency medical care. They are used to restore normal heart rhythms in cases of sudden cardiac arrest, which is more common in older adults due to age-related health conditions. By providing immediate, life-saving intervention, these can significantly improve survival rates and outcomes for the elderly, making them an essential component of emergency response systems in aging societies.

Therefore, all the factors stated above collectively will drive the overall automated external defibrillator market growth.

However, electric shock delivered by automated external defibrillators associated with burns or skin damage at the electrode site, and others may prove to be challenging factors for the automated external defibrillators market growth.

Automated External Defibrillators Market Segment Analysis:

Automated External Defibrillators Market by Product Type (Wearable and Non-Wearable), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of automated external defibrillators, the wearable category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and various key features of wearable defibrillators that enhance their utility and effectiveness.

Wearable automated external defibrillators have gained widespread use as a critical safety measure for individuals at high risk of sudden cardiac arrest, particularly those who may not yet qualify for an implantable defibrillator or are awaiting surgery. Key features of these devices include real-time heart monitoring, which provides continuous surveillance without requiring any action from the user. They are equipped with voice and visual prompts that guide the user or bystanders through the defibrillation process, ensuring that the device is easy to operate even in high-stress situations. Also, these devices are designed to be lightweight and comfortable, allowing patients to go about their daily activities with minimal disruption.

Furthermore, technological advancements and product innovations taking place in the development of wearable automated external defibrillators are likely to propel the automated external defibrillators market growth. For instance, in August 2021, Kestra(TM) Medical Technologies, Inc. announced that the company received premarket approval from the U.S. Food and Drug Administration (FDA) for the ASSURE(R) Wearable Cardioverter Defibrillator system.

Therefore, the widespread uses and various key features of wearable defibrillators that enhance performance and usability are solidifying the impact on the growth of the overall automated external defibrillators market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall automated external defibrillators market:

Among all the regions, North America is expected to dominate the automated external defibrillators market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high prevalence of coronary artery disease, myocardial infarctions, and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the automated external defibrillators market in the North America region during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure among others. Some of the key risk factors associated with heart disease are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

Data from the Canadian Institute for Health Information (2024), stated that in 2022, 2.4 million Canadians were affected by heart disease. Automated External Defibrillators play a critical role in managing severe heart conditions such as CAD and myocardial infarction (heart attack). They are used to restore a normal heart rhythm during sudden cardiac arrest, a potential complication of these conditions. These devices can be found in various settings, including public spaces, hospitals, and emergency response kits. Their ability to provide immediate electrical shocks to the heart can significantly improve survival rates and outcomes in cardiac emergencies. In cases of heart disease, where patients may experience irregular heart rhythms or sudden cardiac arrest, automated external defibrillators are essential tools for prompt intervention and treatment.

Rising product developmental activities by regulatory bodies in the region will further boost the market for automated external defibrillators. For example, in January 2023, Avive Solutions, Inc., received the U.S. Food and Drug Administration (FDA) pre-market approval for its Avive AED(TM), a unique Automated External Defibrillator (AED).

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American automated external defibrillators market.

Automated External Defibrillators Market key players:

Some of the key market players operating in the automated external defibrillators market include Koninklijke Philips N.V., ZOLL Medical Corporation, BPL Medical Technologies, Stryker, Mediana Co., Ltd, CU Medical System Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd, SCHILLER, Bexen Cardio PLC., Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Co., Ltd., Progetti S.r.l., Abbott, HEARTHERO, Kestra Medical Technologies, Inc., Trivitron Healthcare, F. Amiitalia, Shanghai Huifeng Medical Instrument Co.,Ltd, Metrax GmbH, Meditech Equipment Co .,Ltd, and others.

Recent Developmental Activities in the Automated External Defibrillators Market:

• In October 2023, Medtronic plc, received FDA approval for its Aurora EV-ICD(TM) MRI SureScan(TM) Extravascular Implantable Cardioverter-defibrillator and Epsila EV(TM) MRI SureScan(TM) defibrillation lead. These devices are designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
• In June 2021, Rapid Response Revival (RRR) earned CE mark certification in Europe for their automated external defibrillator (AED), CellAED.

Key Takeaways from the Automated External Defibrillators Market Report Study

• Market size analysis for current automated external defibrillators market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the automated external defibrillators market.
• Various opportunities available for the other competitors in the automated external defibrillators market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current automated external defibrillators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for automated external defibrillator market growth in the coming future?

Target Audience who can be benefited from this Automated External Defibrillators Market Report Study

• Automated external defibrillators product providers
• Research organizations and consulting companies
• Automated external defibrillators-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in automated external defibrillators
• Various end-users who want to know more about the automated external defibrillators market and the latest technological developments in the automated external defibrillators market.

Frequently Asked Questions for the Automated External Defibrillators Market:

1. What are Automated External Defibrillators?

Automated external defibrillators are medical devices used to deliver a controlled electric shock to the heart in cases of life-threatening cardiac arrhythmias, such as ventricular fibrillation or pulseless ventricular tachycardia. The purpose of the shock is to reset the heart's electrical activity, allowing it to reestablish a normal rhythm.

2. What is the market for Automated External Defibrillators?

The automated external defibrillators market is estimated to grow at 8.62% CAGR during the forecast period from 2024 to 2030.

3. What are the drivers for the Automated External Defibrillators market?

The automated external defibrillator market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the automated external defibrillators market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Automated External Defibrillators market?

Some of the key market players operating in automated external defibrillators include Koninklijke Philips N.V., ZOLL Medical Corporation, BPL Medical Technologies, Stryker, Mediana Co., Ltd, CU Medical System Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd, SCHILLER, Bexen Cardio PLC., Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Co., Ltd., Progetti S.r.l., Abbott, HEARTHERO, Kestra Medical Technologies, Inc., Trivitron Healthcare, F. Amiitalia, Shanghai Huifeng Medical Instrument Co.,Ltd, Metrax GmbH, Meditech Equipment Co .,Ltd, and others.

5. Which region has the highest share in the Automated External Defibrillators market?

North America is expected to dominate the overall automated external defibrillators market during the forecast period from 2024 to 2030. This can be attributed to several factors including high prevalence of coronary artery disease, myocardial infarctions, and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the automated external defibrillators market in the North America region during the forecast period from 2024 to 2030.